Abstract:RNA editing offers the opportunity to introduce either stable or transient modifications to nucleic acid sequence without permanent off-target effects, but installation of arbitrary edits into the transcriptome is currently infeasible. Here, we describe Programmable RNA Editing & Cleavage for Insertion, Substitution, and Erasure (PRECISE), a versatile RNA editing method for writing RNA of arbitrary length and sequence into existing pre-mRNAs via 5′ or 3′ trans-splicing. In trans-splicing, an exogenous template is introduced to compete with the endogenous pre-mRNA, allowing for replacement of upstream or downstream exon sequence. Using Cas7-11 cleavage of pre-mRNAs to bias towards editing outcomes, we boost the efficiency of RNA trans-splicing by 10–100 fold, achieving editing rates between 5–50% and 85% on endogenous and reporter transcripts, respectively, while maintaining high-fidelity. We demonstrate PRECISE editing across 11 distinct endogenous transcripts of widely varying expression levels, showcasing more than 50 types of edits, including all 12 possible transversions and transitions, insertions ranging from 1 to 1,863 nucleotides, and deletions. We show high efficiency replacement of exon 4 of MECP2, addressing most mutations that drive the Rett Syndrome; editing of SHANK3 transcripts, a gene involved in Autism; and replacement of exon 1 of HTT, removing the hallmark repeat expansions of Huntington′s disease. Whole transcriptome sequencing reveals the high precision of PRECISE editing and lack of off-target trans-splicing activity. Furthermore, we combine payload engineering and ribozymes for protein-free, high-efficiency trans-splicing, with demonstrated efficiency in editing HTT exon 1 via AAV delivery. We show that the high activity of PRECISE editing enables editing in non-dividing neurons and patient-derived Huntington’s disease fibroblasts. PRECISE editing markedly broadens the scope of genetic editing, is straightforward to deliver over existing gene editing tools like prime editing, lacks permanent off-targets, and can enable any type of genetic edit large or small, including edits not otherwise possible with existing RNA base editors, widening the spectrum of addressable diseases.

A Novel Engineered U7 Small Nuclear RNA Scaffold Greatly Increases and ADAR-Mediated Programmable RNA Base Editing

Robust RNA editing via recruitment of endogenous ADARs using circular guide RNAs

Efficient in vitro and in vivo RNA editing via recruitment of endogenous ADARs using circular guide RNAs

Generative machine learning of ADAR substrates for precise and efficient RNA editing

Wobble base improves precision in RNA editing

Precision RNA base editing with engineered and endogenous effectors

Precise in vivo RNA base editing with a wobble-enhanced circular CLUSTER guide RNA

Programmable RNA writing with trans-splicing

Leveraging Endogenous ADAR for Programmable Editing on RNA

Precise RNA editing by recruiting endogenous ADARs with antisense oligonucleotides

An improved SNAP-ADAR tool enables efficient RNA base editing to interfere with post-translational protein modification

Rational design of base, sugar and backbone modifications improves ADAR-mediated RNA editing

Short-Chain Guide RNA for Site-Directed A-to-I RNA Editing

A circularly permuted CasRx platform for efficient, site-specific RNA editing

Development of a selection assay for small guide RNAs that drive efficient site-directed RNA editing

Site-specific regulation of RNA editing with ribose-modified nucleoside analogs in ADAR guide strands

Leveraging Small Molecule-Induced Aptazyme Cleavage for Directed A-to-I RNA Editing

A cytosine deaminase for programmable single-base RNA editing

Programmable RNA base editing via targeted modifications

Nucleoside Analogs in ADAR Guide Strands Enable Editing at 5′-GA Sites